Baseline metabolic tumor volume is an independent prognostic factor in Hodgkin lymphoma

Salim Kanoun, Cedric Rossi, Alina Berriolo-Riedinger, Inna Dygai-Cochet, Alexandre Cochet, Olivier Humbert, Michel Toubeau, Emmanuelle Ferrant, Francois Brunotte, and René-Olivier Casasnovas

Eur J Nucl Med Mol Imaging. 2014 Sep;41(9):1735-43. doi: 10.1007/s00259-014-2783-x. Epub 2014 May 9.

Interim 18F-FDG PET SUVmax reduction is superior to visual analysis to predict early patient’s outcome in Hodgkin lymphoma

Cédric Rossi, Salim Kanoun, Alina Berriolo-Riedinger, Inna Dygai-Cochet, Olivier Humbert, Caroline Legouge, Marie-Lorraine Chrétien, Jean-Noel Bastie, Francois Brunotte, and René-Olivier Casasnovas

J Nucl Med. 2014 Apr;55(4):569-73.


In newly-diagnosed diffuse large B-cell lymphomas, determination of bone marrow involvement with 18FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy

Louis Berthet; Alexandre Cochet; Salim Kanoun; Alina Berriolo-Riedinger; Caroline Legouge; Olivier Humbert; Michel Toubeau; Inna Dygai-Cochet; Olivier Casasnovas; François Brunotte

J Nucl Med. 2013 Aug;54(8):1244-50.


Multimodality MRI and PET for restaging prostate cancer after biochemical failure of the treatment

Cochet A, Kanoun S, Humbert O, Walker P-M, Cormier L, Créhange G, Brunotte F

Cancer Radiother. 2014 Sep 3.


Role of positron emission tomography for the monitoring of response to therapy in breast cancer

Humbert O, Cochet A, Coudert B, Berriolo-Riedinger A, Kanoun S, Brunotte F, Fumoleau P.

Oncologist. 2015 Feb;20(2):94-104. doi: 10.1634/theoncologist.2014-0342. Epub 2015 Jan 5.


Dual diagnostic role of 123I-MIBG scintigraphy in inverted Tako-Tsubo cardiomyopathy

Olivier Humbert, Karim Stamboul, Aurélie Gudjoncik, Salim Kanoun, Carole Richard, Alexandre Cochet, Yves Cottin

Clin Nucl Med. 2015 Oct;40(10):816-8. doi: 10.1097/RLU.0000000000000864.

Identification of biomarkers including 18FDG-PET/CT for early prediction of response to neoadjuvant chemotherapy in Triple Negative Breast Cancer

Olivier Humbert, Jean-Marc Riedinger, Céline Charon-Barra, Alina Berriolo-Riedinger, Isabelle Desmoulins, Bruno Coudert, Salim Kanoun, Charles Coutant, Pierre Fumoleau, Alexandre Cochet, François Brunotte.

Clin Cancer Res. 2015 Dec 15;21(24):5460-8. doi: 10.1158/1078-0432.CCR-15-0384.

Influence of software tool and methodological aspects of total metabolic tumor volume calculation on baseline [18F]FDG PET to predict survival in Hodgkin Lymphoma

Salim Kanoun, Ilan Tal, Alina Berriolo-Riedinger, Cédric Rossi, Jean-Marc Riedinger, Jean-Marc Vrigneaud, Louis Legrand, Olivier Humbert, Olivier Casasnovas, François Brunotte, Alexandre Cochet.

Plos One 2015 Oct 16;10(10):e0140830. doi: 10.1371/journal.pone.0140830. eCollection 2015.


Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)

Anne-Ségolène Cottereau, Stéphanie Becker, Florence Broussais, Olivier Casasnovas, Salim Kanoun, Marjorie Roques, Nathalie Charrier, Sophie Bertrand, Richard Delarue, Christophe Bonnet, Roland Hustinx, Philippe Gaulard, Laurence de Leval, Pierre Vera, Emmanuel Itti, Nicolas Mounier, Corinne Haioun, Hervé Tilly, Michel Meignan.

Ann Oncol. 2016 Jan 19. pii: mdw011.


18F-FDG PET derived tumor blood flow changes after one cycle of neoadjuvant chemotherapy predicts outcome in triple-negative breast cancer.

Humbert O, Riedinger JM, Vrigneaud JM, Kanoun S, Digay-Cochet I, Berriolo-Riedinger A, Toubeau M, Depardon E, Lasserre M, Tisserand S, Fumoleau P, Brunotte F, Cochet A.

J Nucl Med. 2016 Apr 21. pii: jnumed.116.172759